Thursday, 18 March 2004

GENESIS Pharma S.A., one of the fastest growing pharmaceutical companies in Greece, is the official sponsor of the International Conference of Corporate Social Responsibility, entitled "Anchoring a Profitable and Sustainable Future", taking place on the 22nd of March 2004, at the Ledra Marriott hotel. The conference will be organized by the Economist in association with the Federation of Greek Industries (F.G.I.) and with the support of the Hellenic Network for Corporate Social Responsibility.

Mr. Costas Evripides, GENESIS Pharma's CEO, and one of the distinguished speakers at the conference, stated: "We are sponsoring this conference because we believe that Corporate Social Responsibility is an issue of great importance not only for the companies' future but also for the future and advancement of our society".

GENESIS Pharma was incorporated in 1997, with the vision to substantially contribute to the treatment of life- threatening diseases. The company focuses on marketing, sales and distribution of specialised products emerging from biotechnology research for rare and chronic diseases. In reinforcing its role in the market, GENESIS Pharma has accomplished strategic alliances with top biopharmaceutical companies and has developed a strong regional presence in Greece and Southeast Europe. Today it represents top American and European companies of cellular and molecular technology such as Amgen, Biogen Idec, Chiron, Cephalon and Shire.